Featured Research

from universities, journals, and other organizations

Genetic signal prevents immune cells from turning against the body

Date:
August 14, 2014
Source:
Salk Institute for Biological Studies
Summary:
A control signal for the immune system has been discovered that could help treat autoimmune diseases and cancer. "We discovered a mechanism responsible for stabilizing the cells that maintain immune system balance," says the senior author. "The immune system plays a huge role in chronic inflammation and if we can better understand the immune system, we can start to understand and treat many diseases."

From left: Xudong Li, Professor Ye Zheng, Yuqiong Liang
Credit: Salk Institute for Biological Studies

When faced with pathogens, the immune system summons a swarm of cells made up of soldiers and peacekeepers. The peacekeeping cells tell the soldier cells to halt fighting when invaders are cleared. Without this cease-fire signal, the soldiers, known as killer T cells, continue their frenzied attack and turn on the body, causing inflammation and autoimmune disorders such as allergies, asthma, rheumatoid arthritis, multiple sclerosis and type 1 diabetes.

Related Articles


Now, scientists at the Salk Institute have discovered a key control mechanism on the peacekeeping cells that determine if they send a halt signal to the killer T cells. The new research, published today in Cell, could help develop treatments for autoimmune disorders as well as some types of cancer.

"We discovered a mechanism responsible for stabilizing the cells that maintain immune system balance," says senior author Ye Zheng, Salk assistant professor and holder of the Hearst Foundation Developmental Chair. "The immune system plays a huge role in chronic inflammation and if we can better understand the immune system, we can start to understand and treat many diseases."

This balance of signaling for the peacekeeping white blood cells -- known as regulatory T cells ("Tregs") -- is crucial to normal immune response. Aside from causing autoimmune disease by not halting the attack, Tregs can conversely send too many cease-fire signals, which causes killer T cells to ignore threatening invasions. For example, some tumors nefariously surround themselves with a high density of Tregs transmitting the cease-fire signal to protect themselves from being attacked.

"Tregs are like the surveillance system of the immune response," says Zheng. "This surveillance system is key to healthy immune reactions, but it can be kicked into overdrive or turned entirely off."

For about a decade, researchers knew that the key to Tregs' peacekeeping ability is a gene called Foxp3, but they weren't sure how exactly it worked. Researchers also knew that under certain conditions, Tregs can go rogue: they transform into killer T cells and join in the siege. This change means that they lose the ability to send a 'halt' signal and add to inflammation.

In the new paper, Zheng's lab reports that a particular genetic sequence in Foxp3 is solely responsible for the stability of a Treg. If they removed the sequence, dubbed CNS2, Tregs became unstable and often morphed into killer T cells -- the type of cell they are supposed to be controlling -- resulting in autoimmune disease in animal models.

"Foxp3 safeguards Treg to not become anything else," says Zheng. "Previously, very little was known on how Foxp3 did this. We discovered the area of the Foxp3 gene that determines the stability of Tregs and keeps the immune system balanced."

Without this specific region in Foxp3, Treg cells are much more likely to lose their identity and defect into killer T cells when faced with inflammation and infection, says Zheng.

He adds that recent new drugs on the market or in clinical trials are attempting to disable Tregs in tumors to help the body's own immune system fight cancer. This new work provides a target for future cancer drugs as well as autoimmune treatments.

"Now we can try to target this region on Foxp3 to either enhance or reduce the impact of Tregs for treatment of autoimmune disease or cancer, respectively," Zheng adds.


Story Source:

The above story is based on materials provided by Salk Institute for Biological Studies. Note: Materials may be edited for content and length.


Journal Reference:

  1. Xudong Li, Yuqiong Liang, Mathias LeBlanc, Chris Benner, Ye Zheng. Function of a Foxp3 cis-Element in Protecting Regulatory T Cell Identity. Cell, 2014; 158 (4): 734 DOI: 10.1016/j.cell.2014.07.030

Cite This Page:

Salk Institute for Biological Studies. "Genetic signal prevents immune cells from turning against the body." ScienceDaily. ScienceDaily, 14 August 2014. <www.sciencedaily.com/releases/2014/08/140814123430.htm>.
Salk Institute for Biological Studies. (2014, August 14). Genetic signal prevents immune cells from turning against the body. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2014/08/140814123430.htm
Salk Institute for Biological Studies. "Genetic signal prevents immune cells from turning against the body." ScienceDaily. www.sciencedaily.com/releases/2014/08/140814123430.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins